Major points non-believers in IPIX are

New Post Public Reply Private Reply Replies (0) Message Board
petemantx
560
Major points non-believers in IPIX are missing:

Brilacidin is not a haphazardly construed small molecule, but was synthesized by leading doctors from the U of PA using a super computer resulting in what many consider to be the foundational De Novo drug in a new class of medicine, (HDP), which stands for host defense peptide mimetics. This all came about around the year 2000. Polymedix came into being in 2003. In effect, it is among the earliest examples of AI (artificial intelligence) being brought to bear on medicine.

Bottom line: It has all the attributes AND MORE of natural defensins (more because it is said to be 100 times as powerful as natural defensins and 1000 times more selective) and that is why it is so powerful yet so safe.

I would think most everyone has seen the beer commercial where they say what had taken many years in developing a new tasting beer (and whose yeast and brewing was supportive of high volume manufacturing) can now be done in mere seconds or minutes using super computers. Thus, it is easy to see why so many positive traits were incorporated into the B small molecule and the vast majority of negative traits were designed out of the drug. The only negatives I have heard to date regarding Brilacidin is that it may work too effectively and thus has to be reined in for some indications (as in getting thru the stomach via pill prior to releasing B so it doesn't hurt any probiotic bacteria in the stomach and it could possibly cause some eye infection high blood pressure due to being too strong but nothing definite about this).

The above is why so many of us believe Brilacidin is far more than a mere drug, it is a new class of medicine with tremendous upside. Are many even aware that it has been linked to possibly working on COPD, though there are assuredly many other major revenue streams and crippling/deadly conditions against which it will prove effective?

I have always wondered if, when money is available, mgt would consider running Kevetrin thru a super computer to see if it could be more refined into the strongest, safest beast possible? IMO it already is darn near totally safe, so they could mainly work on beefing it up even more.

All in all, many reasons why so many here are enjoying today with a BIG smile on their face and in their heart while those wailing in the street over the share price can't see beyond the tip of their nose as to what they own.
2

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Dell Technologies: A Fresh Look at Investor Sentiment Trends

Updated Category News Views 285

Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...

Continue Reading
Compass Diversified Faces Investigation for Securities Violations

Updated Category News Views 173

Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...

Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities

Updated Category News Views 226

Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...

Continue Reading
Growth Prospects of the Global Medical Imaging Reagents Market

Updated Category News Views 148

Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...

Continue Reading
Mike Tyson Teams Up with GBank Financial in New Venture

Updated Category News Views 285

GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...

Continue Reading